TSHA - Taysha Gene Therapies, Inc.

QQQ $ 448.26 $ -0.62 (-0.14 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 91.84 $ 0.00 (0 %)

GLD $ 219.17 $ -0.07 (-0.03 %)

Previous Close

$ 2.57

Open

$ 2.65

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.53 - $ 2.65

52 Week Range

$ 0.50 - $ 3.89

Volume

2,706,539

Average Volume

Market Cap

594.31M

Beta (5Y Monthly)

$ 1.42

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-19-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-28-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-11-2021	03-31-2021	10-Q
14	03-03-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
05/15/2024 12:01:17

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

Needham Reiterates Buy on Taysha Gene Ther...
05/15/2024 10:04:20

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Taysha Gene Therapies Q1 EPS $(0.10) Beats...
05/14/2024 20:13:48

Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of...

Jefferies Assumes Taysha Gene Therapies at...
05/14/2024 12:20:52

Jefferies analyst Eun Yang assumes Taysha Gene Therapies (NASDAQ:TSHA) with a Buy rating and raises Price Target to $8.

Needham Reiterates Buy on Taysha Gene Ther...
05/02/2024 17:20:02

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Taysha Gene Therapies Announces Regenerati...
05/02/2024 12:10:58

RMAT designation follows FDA's review of available safety and efficacy data from the first three patients dosed with the lo...

11 Analysts Assess Taysha Gene Therapies: ...
04/30/2024 16:00:54

Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:27:19

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

Cantor Fitzgerald Reiterates Overweight on...
04/19/2024 14:43:06

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:37:11

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

applied-digital-reports-downbeat-results-joins-nurix-therapeutics-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Applied Digital Reports Downbeat Results, ...
04/12/2024 12:04:19

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.

Needham Reiterates Buy on Taysha Gene Ther...
04/11/2024 10:26:00

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

roblox-tal-education-and-other-big-stocks-moving-higher-on-wednesday

Roblox, TAL Education And Other Big Stocks...
04/10/2024 14:56:11

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

BlackBerry, Nurix Therapeutics, Tesla And ...
04/09/2024 14:43:45

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

Evaluating Taysha Gene Therapies: Insights...
04/09/2024 12:01:28

Piper Sandler Initiates Coverage On Taysha...
04/09/2024 10:47:32

Piper Sandler analyst Christopher Raymond initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight rating...

spinal-delivery-of-tayshas-gene-therapy-shows-promise-in-rare-childhood-neurodegenerative-disease

Spinal Delivery Of Taysha's Gene Therapy S...
03/21/2024 16:36:27

Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neurop...

Canaccord Genuity Reiterates Buy on Taysha...
03/21/2024 15:37:21

Canaccord Genuity analyst Whitney Ijem reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Micron To Rally Around 134%? Here Are 10 T...
03/21/2024 13:15:39

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...